Three drugs of texel applied for certification in FDA
-
Last Update: 2020-04-03
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Tianshili's 2013 half year report once pointed out that during the period, the company further promoted the phase III clinical trial of Compound Danshen Dropping Pills in the United States, and the two selected products, Shuilinjia and andrographolide dropping pills, have completed fda-ind At the same time, andrographolide dropping pills and Qishenyiqi dropping pills were approved by Canadian botanical medicine, and the internationalization process of traditional Chinese medicine was further advanced The above three new products that have entered the FDA certification team are all second-line and third-line products of Tianshili The annual sales volume of salvianolic acid for injection is expected to exceed 100 million yuan in 2013, and the sales growth of Shuilinjia and andrographolide dropping pills are expected to exceed 30% and 70% respectively in 2013.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
